Kahira Pharmaceuticals & Chemical Industries Company reported earnings results for the third quarter ended March 31, 2022. For the third quarter, the company reported sales was EGP 866.66 million compared to EGP 808.32 million a year ago. Net income was EGP 151.04 million compared to EGP 102.93 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
63.87 EGP | -9.06% | -9.06% | +12.94% |
1st Jan change | Capi. | |
---|---|---|
+12.94% | 19.91M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- CPCI Stock
- News Kahira Pharmaceuticals & Chemical Industries Company
- Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Third Quarter Ended March 31, 2022